12 October 2017
: Case report 
Bone Marrow Mononuclear Cells Transplantation in Treatment of Established Bronchopulmonary Dysplasia: A Case Report
Management of emergency care
Nguyen Thanh Liem1ACDEF*, Tran Lien Anh2BCDEF, Trieu T. Hong Thai2BCDE, Bui Viet Anh3CDDOI: 10.12659/AJCR.905244
Am J Case Rep 2017; 18:1090-1094
Abstract
BACKGROUND: Bronchopulmonary dysplasia (BDP) is an incurable disease. This study reports the successful treatment of a 30-week-old neonate with established bronchopulmonary dysplasia by bone marrow mononuclear cells (BM MNCs) transplantation.
CASE REPORT: The preterm infant with BPD requiring continuous oxygen administration for 4 months post-delivery underwent BM MNCs. Bone marrow was obtained from the patient’s iliac crests and mononuclear cells were isolated by density gradient centrifugation method. BM MNCs were delivered via endotracheal and intravenous routes. After BM MNCs transplantation, remarkable improvements were observed in oxygen saturation and lung CT as the infant was gradually weaned off oxygen supply.
CONCLUSIONS: BM MNCs transplantation offers promising treatment of BPD.
Keywords: Bone Marrow Cells, Bronchopulmonary Dysplasia, Stem Cell Transplantation
In Press
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.946435
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.947160
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.947567
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.948238
Most Viewed Current Articles
21 Jun 2024 : Case report 
100,489
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
53,790
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
36,376
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
07 Jul 2023 : Case report
25,034
DOI :10.12659/AJCR.940200
Am J Case Rep 2023; 24:e940200